Pre-Op Methylprednisolone Beneficial in Knee Arthroplasty

This article originally appeared here.
Share this content:
Pre-Op Methylprednisolone Beneficial in Knee Arthroplasty
Pre-Op Methylprednisolone Beneficial in Knee Arthroplasty

MONDAY, July 31, 2017 (HealthDay News) -- For patients undergoing elective unilateral total knee arthroplasty, preoperative administration of methylprednisolone is associated with reduced circulating markers of endothelial activation and damage, according to a study published online July 28 in Anaesthesia.

Viktoria Lindberg-Larsen, M.D., from Copenhagen University Hospital in Denmark, and colleagues randomized 70 patients undergoing elective unilateral total knee arthroplasty to receive preoperative intravenous methylprednisolone 125 mg or isotonic saline in a 1:1 ratio. Using a standardized multimodal analgesic regime, all procedures were performed under spinal anesthesia without a tourniquet.

The researchers found that, compared with saline, methylprednisolone significantly reduced markers of endothelial damage at 24 hours following surgery (adjusted means expressed by circulating Syndecan-1: 11.6 versus 13.4 ng/mL−1 [P = 0.046]; soluble thrombomodulin: 5.1 versus 5.7 ng/mL−1 [P = 0.009]; sE-Selectin: 64.8 versus 75.7 ng/mL−1 [P = 0.001]; and vascular endothelial growth factor: 35.3 versus 58.5 ng/mL−1 [P < 0.001]). For soluble thrombomodulin, sE-Selectin, and vascular endothelial growth factor, the effect of the intervention increased with time and was more pronounced in patients with high baseline values. Methylprednisolone also correlated with a reduction in C-reactive protein response 24 hours postoperatively (31.1 versus 68.4 mg/L−1 [P < 0.001]).

"These findings may have a positive effect on surgical outcome, but require studies in major surgery," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

Osimertinib Tops Standard EGFR-TKI for EGFR NSCLC

Osimertinib Tops Standard EGFR-TKI for <i>EGFR</i>&#43; NSCLC

Significantly longer median progression-free survival for osimertinib in previously untreated NSCLC

Distinct Features for Drug Use-Related Endophthalmitis

Distinct Features for Drug Use-Related Endophthalmitis

Injection drug users have fewer comorbidities and more improvement in visual acuity after intervention

Dating Violence Victimization, Nonmedical Rx Med Use Linked

Dating Violence Victimization, Nonmedical Rx Med Use Linked

Nonmedical use of prescription drugs linked to dating violence for male, female high school students

is free, fast, and customized just for you!

Already a member?

Sign In Now »